Skip to main content

CORRECTION article

Front. Pharmacol., 05 April 2016
Sec. Inflammation Pharmacology

Corrigendum: Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer

  • 1Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, Oulu, Finland
  • 2Department of Chemistry, University of Kaiserslautern, Kaiserslautern, Germany
  • 3Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany

A corrigendum on
Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer

by Horbach, T., Götz, C., Kietzmann, T., and Dimova, E. Y. (2015) Front. Pharmacol. 6:3. doi: 10.3389/fphar.2015.00003

Correct an error in the reference list. The correction does not affect the scientific validity of the results.

Reference 14 in our paper is wrong:

Refrence 14: Bussiere M., Vance J. E., Campenot R. B., Vance D. E. (2001). Compartmentalization of choline and acetylcholine metabolism in cultured sympathetic neurons. J. Biochem. (Tokyo) 130, 561–568 10.1093/oxfordjournals.jbchem.a003019 is not correct

Correct one citation is:

Bussière, F. I., Michel, V., Mémet, S., Avé, P., Vivas, J. R., Huerre, M., et al. (2010). H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression. Cell Microbiol. 12, 1124–1133. doi: 10.1111/j.1462-5822.2010.01457.x

Author Contributions

All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: USF, phosphorylation, transcription factor, cancer, tumor, signaling, therapeutic target

Citation: Horbach T, Götz C, Kietzmann T and Dimova EY (2016) Corrigendum: Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer. Front. Pharmacol. 7:92. doi: 10.3389/fphar.2016.00092

Received: 03 March 2016; Accepted: 22 March 2016;
Published: 05 April 2016.

Edited and reviewed by: Stephan Immenschuh, Hannover Medical School, Germany

Copyright © 2016 Horbach, Götz, Kietzmann and Dimova. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Elitsa Y. Dimova, elitsa.dimova@oulu.fi

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.